VanEck Associates
CLX icon

VanEck Associates’s Clorox CLX Stock Holding History

VanEck Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284M Sell
2,972,952
-245,427
-8% -$23.6M 0.17% 90
2026
Q1 		$334M Buy
3,218,379
+81,974
+3% +$9.29M 0.25% 76
2025
Q4 		$316M Buy
3,136,405
+426,433
+16% +$46.3M 0.26% 82
2025
Q3 		$334M Buy
2,709,972
+1,312,471
+94% +$163M 0.31% 75
2025
Q2 		$168M Buy
1,397,501
+1,362,163
+3,855% +$182M 0.19% 112
2025
Q1 		$5.2M Sell
35,338
-179
-0.5% -$27.3K 0.01% 698
2024
Q4 		$5.77M Sell
35,517
-1,457,200
-98% -$238M 0.01% 636
2024
Q3 		$237M Buy
1,492,717
+31,510
+2% +$4.67M 0.3% 80
2024
Q2 		$199M Buy
1,461,207
+1,380,724
+1,716% +$192M 0.28% 88
2024
Q1 		$12.3M Sell
80,483
-4,286
-5% -$640K 0.02% 356
2023
Q4 		$12.1M Sell
84,769
-3,806
-4% -$507K 0.02% 331
2023
Q3 		$11.6M Sell
88,575
-4,832
-5% -$734K 0.03% 320
2023
Q2 		$14.9M Sell
93,407
-7,258
-7% -$1.17M 0.03% 288
2023
Q1 		$15.9M Buy
100,665
+11,718
+13% +$1.76M 0.04% 278
2022
Q4 		$12.5M Buy
88,947
+40,821
+85% +$5.79M 0.03% 305
2022
Q3 		$6.18M Buy
48,126
+3,552
+8% +$513K 0.02% 394
2022
Q2 		$6.28M Buy
+44,574
New +$6.37M 0.02% 412
2018
Q2 		– Sell
-88
Closed -$12K – 853
2018
Q1 		$12K Buy
+88
New +$11.8K ﹤0.01% 727

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VanEck Associates's CLX Position: Q2 2026 in Review

VanEck Associates reduced its Clorox (CLX) stake by 7.6% in Q2 2026, selling an estimated $23.6M and leaving 2,972,952 shares worth $284M. The position accounts for 0.17% of the portfolio, ranked #90.

VanEck Associates first reported a position in CLX in Q1 2018 and has held it in 18 quarters since. The position peaked at $334M in Q3 2025. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • VanEck Associates held 2,972,952 shares of Clorox worth $284M as of Q2 2026.
  • VanEck Associates sold 245,427 Clorox shares in Q2 2026, an estimated $23.6M.
  • Clorox made up 0.17% of VanEck Associates's portfolio in Q2 2026, its #90 holding.
  • VanEck Associates first reported a position in Clorox in Q1 2018 and has held it in 18 quarters since.
  • VanEck Associates's Clorox position peaked at $334M in Q3 2025.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.